Saba Capital Management, L.P. sold HQL

January 30, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 21,835 shares of Abrdn Life Sciences Investors at $14.16 per share, a transaction worth $309.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.